Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis. (Q52894988)

9 May 2018

title

Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis. (English)

1 reference

9 May 2018

1 reference

Antje Voigt

9

0 references

Ulrike Kuckelkorn

5

object named as

Ulrike Kuckelkorn

1 reference

9 May 2018

author name string

Anna Rahnefeld

1

1 reference

9 May 2018

Frédéric Ebstein

2

1 reference

9 May 2018

Nadine Albrecht

3

1 reference

9 May 2018

Elisa Opitz

4

1 reference

9 May 2018

Karl Stangl

6

1 reference

9 May 2018

Armin Rehm

7

1 reference

9 May 2018

Peter M Kloetzel

8

1 reference

9 May 2018

language of work or name

English

0 references

publication date

29 July 2011

1 reference

9 May 2018

European Journal of Immunology

published in

1 reference

9 May 2018

volume

41

1 reference

9 May 2018

issue

9

1 reference

9 May 2018

page(s)

2774-2781

1 reference

9 May 2018

Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

β2-Microglobulin-Associated Regulation of Interferon-γ and Virus-Specific Immunoglobulin G Confer Resistance Against the Development of Chronic Coxsackievirus Myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Protective role for interferon-beta in coxsackievirus B3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Innate immune recognition of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Cross-priming in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Antigen processing by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Immunity by ubiquitylation: a reversible process of modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

The role of the interferon regulatory factor (IRF) family in dendritic cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

The major substrates for TAP in vivo are derived from newly synthesized proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.201041039

1 reference

9 May 2018

1 reference

9 May 2018